Abstract:Androgenetic alopecia (AGA) is highly prevalent in current society but lacks effective treatments. The dysregulation of the hair follicle niche induced by excessive reactive oxygen species (ROS) and insufficient vascularization in the perifollicular microenvironment is the leading cause of AGA. Herein, we designed a ceria nanozyme (CeNZ)-integrated microneedles patch (Ce-MNs) that can alleviate oxidative stress and promote angiogenesis simultaneously to reshape the perifollicular microenvironment for AGA treatment. On the basis of the excellent mechanical strength of Ce-MNs, the encapsulated CeNZs with catalase- and superoxide-mimic activities can be efficiently delivered into skin to scavenge excessive ROS. Moreover, the mechanical stimulation induced by the administration of MNs can remodel the microvasculature in the balding region. Compared with minoxidil, a widely used clinical drug for AGA treatment, Ce-MNs exhibited accelerated hair regeneration in the AGA mouse model at a lower administration frequency without inducing significant skin damage. Consequently, such a safe and perifollicular microenvironment-shaping MNs patch shows great potential for clinical AGA treatment.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.1c05272?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.1c05272</a>.XRD pattern, XPS analysis, TGA curves, and FT-IR spectra of hydrophobic CeNZs and DSPE-mPEG<sub>2000</sub>-modified CeNZs, TEM image, DLS analysis, and HORAC of CeNZs, preparation process scheme, release kinetics assessment, cell viability assay, ROS-scavenging activity and cellular antioxidant effect of Ce-MNs, mechanical strength evaluation of Ce-MNs and Blank-MNs, <i>in vivo</i> biodistribution of Ce element, photographs of mouse hair regrowth status, regenerated hair coverage and hair density on day 28, hair cycle transition assessment including the quantification of pigmented day after depilation, time profile of hair-covered area and activation of hair follicle stem cell on day 10, epidermal thickness and skin thickness evaluation, H&E staining of normal skin and Ce-MNs-treated skin, quantification of MDA on day 14 and quantification of VEGF on day 7, 14, and 21 (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.1c05272/suppl_file/nn1c05272_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

PROTAC Degraders of Androgen Receptor-Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment Via Single Topical Administration.

Discovery of a Novel Non-invasive AR PROTAC Degrader for the Topical Treatment of Androgenetic Alopecia

Discovery of (2S)-N-(6-cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide As a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment

Microneedle Delivery Platform Integrated with Codelivery Nanoliposomes for Effective and Safe Androgenetic Alopecia Treatment

Remodel the Perifollicular Microenvironment Via Minoxidil-loaded Microneedle Patch and Cold Atmospheric Plasma for Treating Androgenetic Alopecia

Bioengineered Polyester Nanoparticles for the Synergistic Treatment of Androgenic Alopecia Via the Suppression of 5Α-Reductase and Knockdown of Androgen Receptor

Efficacy of Asymmetric siRNA Targeting Androgen Receptors for the Treatment of Androgenetic Alopecia

Platinum Nanozyme‐Loaded Dissolving Microneedles Scavenge ROS and Promote Lineage Progression for Androgenetic Alopecia Treatment

Discovery of (2 S )- N -(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment

Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia

Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment

An androgenetic alopecia remedy based on marine collagen peptide-incorporated dissolving microneedles

Synergistic therapeutic effect of ginsenoside Rg3 modified minoxidil transfersomes (MXD-Rg3@TFs) on androgenic alopecia in C57BL/6 mice

Fabrication of carboxymethyl cellulose/hyaluronic acid/polyvinylpyrrolidone composite pastes incorporation of minoxidil-loaded ferulic acid-derived lignin nanoparticles and valproic acid for treatment of androgenetic alopecia

Ceria Nanozyme-Integrated Microneedles Reshape the Perifollicular Microenvironment for Androgenetic Alopecia Treatment

Co-delivery of minoxidil and tocopherol acetate ethosomes to reshape the hair Follicular Microenvironment and promote hair regeneration in androgenetic alopecia

Facile fabrication of cedrol nanoemulsions with deep transdermal delivery ability and high safety for effective androgenic alopecia treatment

Multifunctional ionic liquids-mediated topical delivery of minoxidil and EGCG for treating androgenic alopecia through promoting angiogenesis and scavenging ROS

Engineered Exosomes Biopotentiated Hydrogel Promote Hair Follicle Growth via Reprogramming the Perifollicular Microenvironment

Treatment of Androgenetic Alopecia Using PRP to Target Dysregulated Mechanisms and Pathways

Traditional Scraping (Gua Sha) Combined with Copper-Curcumin Nanoparticle Oleogel for Accurate and Multi-Effective Therapy of Androgenic Alopecia